Literature DB >> 12642307

Five year results of viscocanalostomy.

T Shaarawy1, C Nguyen, C Schnyder, A Mermoud.   

Abstract

AIM: To prospectively study the success rate and complications of viscocanalostomy, a non-penetrating glaucoma surgery.
METHODS: Prospective non-randomised consecutive case series of 57 eyes (57 patients) with medically uncontrolled primary and secondary open angle glaucoma. Viscocanalostomy was performed on all participants with injection of viscoelastic in the surgically created ostia of Schlemm's canal as well as in the scleral bed, the superficial scleral flap was loosely sutured. Intraocular pressure, visual acuity, and number of goniopunctures were measured.
RESULTS: The mean follow up period was 34.1 months. The mean preoperative intraocular pressure (IOP) was 24.6 mm Hg; while the mean postoperative IOP was 5.6 mm Hg at day 1 and 13.9 mm Hg at 36 month. Patients who achieved IOP below 21 mm Hg with or without medication were 90% at 60 months, complete success rate (IOP<21 mm Hg without medication) was 60% at 60 months. 21 patients (37%) needed Nd:YAG goniopuncture postoperatively to control raised IOP, mean time for goniopuncture application was 9.4 months, mean pre-goniopuncture IOP was 20.4 mm Hg and mean postgoniopuncture IOP was 12.6 mm Hg (p <0.0001).
CONCLUSION: Viscocanalostomy appears to be a promising modification of filtering surgery.

Entities:  

Mesh:

Year:  2003        PMID: 12642307      PMCID: PMC1771626          DOI: 10.1136/bjo.87.4.441

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  23 in total

1.  Viscocanalostomy for open-angle glaucoma in black African patients.

Authors:  R Stegmann; A Pienaar; D Miller
Journal:  J Cataract Refract Surg       Date:  1999-03       Impact factor: 3.351

2.  Long-term post trabeculectomy intraocular pressures.

Authors:  S K Akafo; D B Goulstine; A R Rosenthal
Journal:  Acta Ophthalmol (Copenh)       Date:  1992-06

3.  Viscocanalostomy: a pilot study.

Authors:  R G Carassa; P Bettin; R Brancato
Journal:  Acta Ophthalmol Scand Suppl       Date:  1998

4.  Laser suture lysis after trabeculectomy.

Authors:  J A Savage; G P Condon; R A Lytle; R J Simmons
Journal:  Ophthalmology       Date:  1988-12       Impact factor: 12.079

5.  Management of anterior chamber depth after trabeculectomy.

Authors:  W C Stewart; M B Shields
Journal:  Am J Ophthalmol       Date:  1988-07-15       Impact factor: 5.258

6.  The complications of trabeculectomy (a 20-year follow-up).

Authors:  P G Watson; C Jakeman; M Ozturk; M F Barnett; F Barnett; K T Khaw
Journal:  Eye (Lond)       Date:  1990       Impact factor: 3.775

7.  Surgical effects of trabeculotomy ab externo on adult eyes with primary open angle glaucoma and pseudoexfoliation syndrome.

Authors:  H Tanihara; A Negi; M Akimoto; H Terauchi; A Okudaira; J Kozaki; A Takeuchi; M Nagata
Journal:  Arch Ophthalmol       Date:  1993-12

8.  Fluorouracil Filtering Surgery Study one-year follow-up. The Fluorouracil Filtering Surgery Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1989-12-15       Impact factor: 5.258

9.  The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven-year results.

Authors: 
Journal:  Ophthalmology       Date:  1998-07       Impact factor: 12.079

10.  Viscocanalostomy: a pilot study.

Authors:  R G Carassa; P Bettin; M Fiori; R Brancato
Journal:  Eur J Ophthalmol       Date:  1998 Apr-Jun       Impact factor: 1.922

View more
  21 in total

1.  Contra: non-penetrating surgery and filtration?

Authors:  Thomas S Dietlein; Günter K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-09       Impact factor: 3.117

2.  Influence of non-penetrating glaucoma surgery on aqueous outflow facility in isolated porcine eyes.

Authors:  T Shaarawy; R Wu; A Mermoud; J Flammer; I O Haefliger
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

3.  Non-penetrating intracanalicular partial trabeculectomy via the ostia of Schlemm's canal.

Authors:  Alexey V Dashevsky; Ines M Lanzl; Konstantin E Kotliar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-23       Impact factor: 3.117

4.  Viscocanalostomy versus trabeculectomy in patients with bilateral high-tension glaucoma.

Authors:  Alper Yarangümeli; Serkan Güreser; Ozlem Gürbüz Köz; Atilla Halil Elhan; Gülcan Kural
Journal:  Int Ophthalmol       Date:  2005-09-29       Impact factor: 2.031

5.  Nd:YAG laser goniopuncture in viscocanalostomy: penetration in non-penetrating glaucoma surgery.

Authors:  Mehmet Numan Alp; Alper Yarangumeli; Ozlem Gurbuz Koz; Gulcan Kural
Journal:  Int Ophthalmol       Date:  2009-05-29       Impact factor: 2.031

6.  Viscocanalostomy versus trabeculotomy ab externo in primary congenital glaucoma: 1-year follow-up of a prospective controlled pilot study.

Authors:  B N Noureddin; C P El-Haibi; A Cheikha; Z F Bashshur
Journal:  Br J Ophthalmol       Date:  2006-07-12       Impact factor: 4.638

7.  Combined cataract and glaucoma surgery with mitomycin C: phacoemulsification-trabeculectomy compared to phacoemulsification-deep sclerectomy.

Authors:  C L Funnell; M Clowes; N Anand
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

8.  Comparative study of phacoemulsification-subscleral trabeculectomy versus phacoemulsification-deep sclerectomy.

Authors:  Tahrwat H Mokbel; Asaad A Ghanem; Ashraf I Moawad; Ehab M Nafie; Ehab H Nematallah
Journal:  Saudi J Ophthalmol       Date:  2009-10-28

9.  Low first postoperative day intraocular pressure as a positive prognostic indicator in deep sclerectomy.

Authors:  T Shaarawy; J Flammer; G Smits; A Mermoud
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

10.  Nonpenetrating very deep sclerectomy with hyaluronic acid implant vs trabeculectomy--a 2-year follow-up.

Authors:  Rafał Leszczyński; Maria Formińska-Kapuścik; Beata Bubała-Stachowicz; Ewa Mrukwa-Kominek; Erita Filipek; Krzysztof Pawlicki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-09       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.